 Pfizer's stock rose 2.8% in early trading today after the drug company said it's progressing in developing a once-daily pill for obesity. The pharmaceutical giant says it's chosen a preferred modified release formulation of its experimental drug Denuglipron, which is similar to Novozozempic and Wagovi, but it's taken orally rather than injected.